Pulse Biosciences

Yahoo Finance • last year

Pulse Biosciences to Present at the 35th Annual Piper Sandler Healthcare Conference

HAYWARD, Calif., November 15, 2023--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company primarily focused on leveraging its novel and proprietary CellFX Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment o... Full story

Yahoo Finance • last year

UPDATE Pulse Biosciences Announces New Time for Third Quarter 2023 Financial Results Conference Call

Pulse Biosciences will host a conference call at 9:00 am PT / 12:00 pm ET on Monday, November 13, 2023 HAYWARD, Calif., November 10, 2023--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE, "the Company"), a company primarily focused... Full story

Yahoo Finance • 2 years ago

Pulse Biosciences’ Nanosecond Pulsed Field Ablation (nsPFA™) Technology to be Featured in Several Presentations at The Heart Rhythm 2023 Annual Meeting

HAYWARD, Calif., May 18, 2023--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a company leveraging its novel and proprietary Nanosecond Pulsed Field Ablation (nsPFA) technology for the treatment of atrial fibrillation, today anno... Full story

Yahoo Finance • 2 years ago

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2023 Earnings Call Transcript

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q1 2023 Earnings Call Transcript May 11, 2023 Pulse Biosciences, Inc. misses on earnings expectations. Reported EPS is $-0.23 EPS, expectations were $-0.22. Operator: Good afternoon, ladies and gentl... Full story

Yahoo Finance • 2 years ago

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2022 Earnings Call Transcript

Pulse Biosciences, Inc. (NASDAQ:PLSE) Q4 2022 Earnings Call Transcript March 30, 2023 Operator: Ladies and gentlemen, greetings, and welcome to the Pulse Biosciences' Fourth Quarter 2022 Earnings Conference Call. At this time all particip... Full story

Yahoo Finance • 3 years ago

Stock rebound uncertain for U.S. biotechs as risks multiply for investors

U.S. biotechs and other health care stocks accounted for about 11% of all losses in U.S. equity values during the five-month period analyzed by The Business Journals.... Full story

Yahoo Finance • 3 years ago

Pulse Biosciences Reports First Quarter 2022 Financial Results

HAYWARD, Calif., May 11, 2022--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced financial... Full story

Yahoo Finance • 3 years ago

PLSE DEADLINE ALERT: ROSEN, TOP RANKED INVESTOR COUNSEL, Encourages Pulse Biosciences, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important Monday Deadline in Securities Class Action – PLSE

NEW YORK, April 16, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pulse Biosciences, Inc. (NASDAQ: PLSE) between January 12, 2021 and February 7, 2022, inclusive... Full story

Yahoo Finance • 3 years ago

DEADLINE ALERT for SPWR, PLSE, BFLY, GWGH: Law Offices of Howard G. Smith Reminds Investors of Class Actions on Behalf of Shareholders

BENSALEM, Pa., April 15, 2022 (GLOBE NEWSWIRE) -- Law Offices of Howard G. Smith reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies. Investors have until the... Full story

Yahoo Finance • 3 years ago

SPWR, PLSE & MP Investor Alert: Bronstein, Gewirtz & Grossman, LLC Reminds Investors of Upcoming Class Action Deadlines and to Contact the Firm

NEW YORK, April 12, 2022 (GLOBE NEWSWIRE) -- Attorney Advertising -- Bronstein, Gewirtz & Grossman, LLC reminds investors that a class action lawsuit has been filed against the following publicly-traded companies. You can review a copy o... Full story

Yahoo Finance • 3 years ago

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Acutus, Pulse, SunPower, and Butterfly and Encourages Investors to Contact the Firm

NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Acutus Medical, Inc. (NA... Full story

Yahoo Finance • 3 years ago

PLSE FINAL DEADLINE: ROSEN, A TOP RANKED LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses to Secure Counsel Before Important April 18 Deadline in Securities Class Action – PLSE

NEW YORK, April 11, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pulse Biosciences, Inc. (NASDAQ: PLSE) between January 12, 2021 and February 7, 2022, inclusive... Full story

Yahoo Finance • 3 years ago

Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Pulse Biosciences, Inc. (PLSE)

LOS ANGELES, April 07, 2022 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming April 18, 2022 deadline to file a lead plaintiff motion in the class action filed on behalf of investors who purchased... Full story

Yahoo Finance • 3 years ago

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Fennec, Astra, Acutus, and Pulse and Encourages Investors to Contact the Firm

NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Fennec Pharmaceuticals,... Full story

Yahoo Finance • 3 years ago

PLSE FINAL DEADLINE: ROSEN, A TOP RANKED FIRM, Encourages Pulse Biosciences, Inc. Investors With Losses Over $100K to Secure Counsel Before Important April 18 Deadline in Securities Class Action – PLSE

NEW YORK, April 06, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pulse Biosciences, Inc. (NASDAQ: PLSE) between January 12, 2021 and February 7, 2022, inclusive... Full story

Yahoo Finance • 3 years ago

Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Pulse, SunPower, Butterfly, and GWG and Encourages Investors to Contact the Firm

NEW YORK, April 01, 2022 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, reminds investors that class actions have been commenced on behalf of stockholders of Pulse Biosciences, Inc.... Full story

Yahoo Finance • 3 years ago

Pulse Biosciences Reports Fourth Quarter & Full Year 2021 Financial Results

HAYWARD, Calif., March 31, 2022--(BUSINESS WIRE)--Pulse Biosciences, Inc. (Nasdaq: PLSE), a novel bioelectric medicine company commercializing the CellFX® System powered by Nano-Pulse Stimulation™ (NPS™) technology, today announced financi... Full story

Yahoo Finance • 3 years ago

全球領先的律師事務所 ROSEN 鼓勵損失超過 10 萬美元的 Pulse Biosciences, Inc. 投資者在 4 月 18 日的證券集體訴訟重要截止日期前尋求法律意見 – PLSE

紐約, March 30, 2022 (GLOBE NEWSWIRE) -- 為何︰全球投資者權益律師事務所 Rosen Law Firm 提醒在 2021 年 1 月 12 日至 2022 年 2 月 7 日（包括首尾兩天）期間（「集體訴訟期間」）購買 Pulse Biosciences, Inc. (NASDAQ: PLSE) 證券的購買者注意，2022 年 4 月 18 日是首席原告人截止日期的重要日子。 何事：如果您在集體訴訟期間購買了 Pulse 證券，您可... Full story

Yahoo Finance • 3 years ago

ROSEN, A GLOBAL AND LEADING LAW FIRM, Encourages Pulse Biosciences, Inc. Investors with Losses Exceeding $100K to Secure Counsel Before Important April 18 Deadline in Securities Class Action – PLSE

NEW YORK, March 29, 2022 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Pulse Biosciences, Inc. (NASDAQ: PLSE) between January 12, 2021 and February 7, 2022, inclusive... Full story

Yahoo Finance • 3 years ago

DEADLINE ALERT for FENC, AFIB, SPWR, and PLSE: The Law Offices of Frank R. Cruz Reminds Investors of Class Actions on Behalf of Shareholders

LOS ANGELES, March 28, 2022 (GLOBE NEWSWIRE) -- The Law Offices of Frank R. Cruz reminds investors that class action lawsuits have been filed on behalf of shareholders of the following publicly-traded companies.  Investors have until the... Full story